deaths from tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Effects of Tirzepatide on the

Consuming adequate calcium through diet and supplementation is associated with higher bone-mineral density (Napoli 2007)

The combination of naltrexone and semaglutide has emerged as a potential strategy for weight management, with some clinical research suggesting synergistic effects on appetite suppression and metabolism

A 28.7% average weight loss at 68 weeks coupled with transformative improvements in knee osteoarthritis pain, cardiovascular risk markers, and metabolic health represents a genuine advance in obesity treatment

Activation of GLP-1 Rs triggers glucose-dependent insulin secretion, suppression of glucagon release, delayed gastric emptying, and promotion of satiety (Kim and Egan, 2008